Synta's (SNTA) Ganetespib Could See Extra Exclusivity Following FDA Meeting - Roth
Go back to Synta's (SNTA) Ganetespib Could See Extra Exclusivity Following FDA Meeting - RothSynta Pharmaceuticals, Inc. (NASDAQ: SNTA) | Delayed: 0.34 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $0.34 | 52 Week High | $2.23 | |||
Open | $4.10 | 52 Week Low | $0.15 | |||
Day High | $0.34 | P/E | N/A | |||
Day Low | $0.34 | EPS | $-1.25 | |||
Volume | 325,183 |